SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027588
Filing Date
2021-05-13
Accepted
2021-05-13 16:24:37
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itos-10q_20210331.htm 10-Q 2063548
2 EX-10.1 itos-ex101_86.htm EX-10.1 319065
3 EX-31.1 itos-ex311_6.htm EX-31.1 18391
4 EX-31.2 itos-ex312_8.htm EX-31.2 22688
5 EX-32.1 itos-ex321_7.htm EX-32.1 12234
  Complete submission text file 0001564590-21-027588.txt   6383551

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itos-20210331.xml EX-101.INS 985422
7 XBRL TAXONOMY EXTENSION SCHEMA itos-20210331.xsd EX-101.SCH 56468
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itos-20210331_cal.xml EX-101.CAL 43376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itos-20210331_def.xml EX-101.DEF 182643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itos-20210331_lab.xml EX-101.LAB 391849
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itos-20210331_pre.xml EX-101.PRE 303806
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 21920019
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences